Related Experiment Video
Updated: May 26, 2025

05:16
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
6.7K
Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived
Naoki Suzuki1,2
1Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Molecular Therapy. Nucleic Acids
|February 24, 2025
Abstract
No abstract available in PubMed .

